ADMGCN: graph convolutional network for Alzheimer’s disease diagnosis with a meta-learning paradigm
Bioinformatics · 01.12.2025 · 41 (12)
DOI: 10.1093/bioinformatics/btaf580 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioinformatics, online erschienen am 28.10.2025. Verfasst von Xiaowen Sun und 3 weiteren Autor:innen. Beteiligte Einrichtung: College of Medical Information and Engineering, Ningxia Medical University, Yinchuan 750004, China. Hauptthemen laut MEDLINE: Alzheimer Disease, Deep Learning, Neural Networks, Computer. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China Projects, Interdisciplinary Research Program of Ningxia Medical University.
Themen: Demenz
Abstract (Originalsprache)
Motivation Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by memory loss and cognitive decline. While graph convolutional networks (GCNs) have emerged as popular tools for AD diagnosis due to their ability to handle structural information and fuse multi-modal features, deep learning approaches face significant challenges including the requirement for large datasets and sensitivity to unbalanced label distributions in AD research. To address these limitations and enhance the flexibility of GCNs, we propose a graph convolutional network based on the meta-learning paradigm (ADMGCN) for early AD diagnosis. This approach incorporates weighting and dimensionality reduction to improve performance, storage, and training efficiency. By leveraging meta-learning, we sample subjects to create numerous label-balanced tasks, maximizing data utilization and mitigating the impact of label imbalance. Additionally, the meta-learning framework enables rapid adaptation to new tasks and facilitates independent testing of the GCN. Results Our model, ADMGCN, was extensively validated on the Alzheimer’s Disease Neuroimaging Initiative datasets. It achieved a maximum accuracy of 73.7% in the multi-classification task for early AD diagnosis. In three binary classification tasks, the model also demonstrated strong performance, achieving accuracies of 92.8%, 88.0%, and 79.6%, respectively. These results confirm that the proposed method provides an effective approach and worthwhile support for the early diagnosis of Alzheimer’s disease. Availability and implementation ADMGCN is freely available at https://github.com/WendySun16/ADMGCN.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- College of Medical Information and Engineering, Ningxia Medical University, Yinchuan 750004, China.
- Research Center for Mathematics and Interdisciplinary Sciences (Ministry of Education Frontiers Science Center for Nonlinear Expectations), Shandong University, Qingdao 266237, China.
- Academy of Mathematics and Systems Science, Chinese Academy of Sciences, Beijing, China.
- School of Mathematical Sciences, University of Chinese Academy of Sciences, Beijing 100190, China.
- Syneron Opal, 10281, Cayman Island.
ORCID-Profile: Xiaowen Sun, Jiahao Li, Renmin Han
Förderung
- National Natural Science Foundation of China Projects
- Interdisciplinary Research Program of Ningxia Medical University
Zitieren
APA
Sun, X., Li, J., Yan, G., & Han, R. (2025). ADMGCN: graph convolutional network for Alzheimer’s disease diagnosis with a meta-learning paradigm. Bioinformatics, 41(12). https://doi.org/10.1093/bioinformatics/btaf580
Vancouver
Sun X, Li J, Yan G, Han R. ADMGCN: graph convolutional network for Alzheimer’s disease diagnosis with a meta-learning paradigm. Bioinformatics. 2025;41(12). doi:10.1093/bioinformatics/btaf580
BibTeX
@article{Sun2025,
author = {Sun, Xiaowen and Li, Jiahao and Yan, Guiying and Han, Renmin},
title = {ADMGCN: graph convolutional network for Alzheimer’s disease diagnosis with a meta-learning paradigm},
journal = {Bioinformatics},
year = {2025},
volume = {41},
number = {12},
doi = {10.1093/bioinformatics/btaf580}
}
EUVIMED